程巳雪
开通时间：..
最后更新时间：..
个人信息
出生日期 1971年4月30日
（左栏的日期为网络系统自动填写，无法修改，可能的原因是系统只填写到月，日期被默认为1 。以此处日期为准。）
教育与研究经历
学士：华南理工大学 1992年
硕士：中国科学技术大学 1995年
博士：新加坡国立大学 2000年
2000年1月-2001年1月：新加坡 材料研究与工程研究所（研究助理）
2001年1月-2003年11月：武汉大学 化学学院 生物医用高分子材料教育部开放/重点实验室（副教授）
2003年11月-：武汉大学 化学学院 生物医用高分子材料教育部重点实验室（教授）
研究领域与兴趣
生物医用高分子
药物及基因传递材料
生物材料的自组装
疾病诊断与治疗相关生物材料
教学情况
主讲本科生课程《科技论文阅读与写作》
主讲研究生课程《专业英语与科技写作》《博士英语》
近年代表论文
Han D, He XY, Huang Y, Gao M, Guo T, Ren XH, Liao XR, Chen XS, Pang X, Cheng SX*, A multifunctional delivery system for remodulating cell behaviors of circulating malignant cells to prevent cell fusion, Adv. Sci. 2023, 10, 2303309.
Che YJ, Ren XH, Wang ZW*, Wu Q, Xing K, Zhang M, Xu C, Han D, Yuan S, Zheng SH, Chen YY, Liao XR, Shi F, Zhong XH, Cai X, Cheng SX*, Lymph node targeted drug delivery for effective immunomodulation to prolong the long-term survival after heart transplantation, Adv. Mater. 2023, 35, 2207227.
Han D, Ren XH, Liao XR, He XY,* Guo T,* Chen XS, Pang X, Cheng SX*, A multiple targeting nanoprobe for identifying cancer metastatic sites based on detection of various mRNAs in circulating tumor cells, Nano Lett. 2023, 23, 3678−3686.
Han D, Ren XH, He XY, Chen XS, Pang X, Cheng SX*, Aptamer/peptide-functionalized nanoprobe for detecting multiple miRNAs in circulating malignant cells to study tumor heterogeneity, ACS Biomater. Sci. Eng. 2023, 9, 5832−5842.
Ren XH, Han D, He XY, Guo T, Chen XS, Pang X, Cheng SX*, Multi-Targeting nano-systems targeting heterogenous cancer cells for therapeutics and biomarker detection, Adv. Healthc. Mater. 2023, 12, 2202155.
Xu C, Ren XH, Han D, Peng Y, Lei JJ, Yu LX, Liu LJ, Xu WC, Cheng SX*, Precise detection on cell-cell fusion by a facile molecular beacon-based method, Anal. Chem. 2022, 94, 17334-17340.
Xu C, He XY, Ren XH, Han D, Cheng SX*, Detection of mRNAs of ribosomal protein L15 and E-cadherin in living circulating tumor cells at single cell resolution to study tumor heterogeneity, Anal. Chem. 2022, 94, 10610−10616.
Ren XH, He XY, Xu C, Han D, Cheng SX*, Functional tumor targeting nano-systems for reprogramming circulating tumor cells with in situ evaluation on therapeutic efficiency at the single-cell level, Adv. Sci. 2022, 2105806.
Han D, Xu C, Ren XH, Peng Y, Xu B, Song JL, Chen J, Cheng SX*, In situ detection on nanotoxicity in living cells based on multiple miRNAs probed by peptide functionalized nanoprobe, Anal. Chem. 2022, 94, 2399−2407.
Ren XH, Xu C, Li LL, Zuo Y, Han D, He XY*, Cheng SX*, A targeting delivery system for effective genome editing in leukemia cells to reverse malignancy, J. Control. Release 2022, 343, 645–656.
Xu C, He XY, Ren XH, Cheng SX*, Direct detection of intracellular miRNA in living circulating tumor cells by tumor targeting nanoprobe in peripheral blood, Biosen. Bioelectron. 2021, 190, 113401.
Ai SL, Wang CX, Peng Y, Tu Y, Lei JJ, Xu C, Ren XH, Cheng SX*, An albumin-based therapeutic nanosystem for photosensitizer/protein co-delivery to realize synergistic cancer therapy, ACS Appl. Bio Mater. 2021, 4, 4946−4952.
He XY, Ren XH, Peng Y, Zhang JP, Ai SL, Liu BY, Xu C, Cheng SX*, Aptamer/peptide functionalized genome editing system for effective immune restoration through reversal of PD-L1 mediated cancer immunosuppression, Adv. Mater. 2020, 32, 2000208.
Xu C, He XY, Peng Y, Dai BS, Liu BY, Cheng SX*, Facile strategy to enhance specificity and sensitivity of molecular beacons by an aptamer-functionalized delivery vector, Anal. Chem. 2020, 92, 2088-2096.
Ren XH, He XY, Liu BY, Xu C, Cheng SX*, Self-assembled plasmid delivery system for PPM1D knockout to reverse tumor malignancy, ACS Appl. Bio Mater. 2020, 3, 7831-7839.
He XY, Liu BY, Peng Y, Zhuo RX, Cheng SX*, Multifunctional vector for delivery of genome editing plasmid targeting β‑catenin to remodulate cancer cell properties, ACS Appl. Mater. Interfaces 2019, 11, 226-237.
Liu BY, He XY, Xu C, Ren XH, Zhuo RX, Cheng SX*, Peptide and aptamer decorated delivery system for targeting delivery of Cas9/sgRNA plasmid to mediate anti-tumor genome editing, ACS Appl. Mater. Interfaces 2019, 11, 23870-23879.
Ai SL, He XY, Liu BY, Zhuo RX, Cheng SX*, Targeting delivery of oligodeoxynucleotides to macrophages by mannosylated cationic albumin for immune stimulation in cancer treatment, Mol. Pharm. 2019, 16, 2616-2625.
Xu L, Wang SB, Xu C, Han D, Ren XH, Zhang XZ, Cheng SX*, Multifunctional albumin-based delivery system generated by programmed assembly for tumor-targeted multimodal therapy and imaging, ACS Appl. Mater. Interfaces 2019, 11, 38385-38394.
Liu BY, He XY, Zhuo RX, Cheng SX*, Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector, Nanoscale 2018, 10, 21209-21218.
Liu BY, He XY, Zhuo RX, Cheng SX*, Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors, J. Control. Release 2018, 291, 90-98.
He XY, Liu BY, Xu C, Zhuo RX, Cheng SX*, A multi-functional macrophage and tumor targeting gene delivery system for regulation of macrophage polarity and reversal of cancer immunoresistance, Nanoscale 2018, 10, 15578-15587.
Liu BY, He XY, Xu C, Xu L, Ai SL, Cheng SX*, Zhuo RX*, A dual-targeting delivery system for effective genome editing and in situ detecting related protein expression in edited cells, Biomacromolecules 2018, 19, 2957-2968.
（备注：英文版网页介绍为在线系统根据中文版自动翻译而来，因此有较多不规范的英文语言表达，特此说明并深表歉意。）
邮编 :
通讯/办公地址 :
办公室电话 :
邮箱 :
华南理工大学
本科(学士)
学士
中国科学技术大学
硕士研究生毕业
硕士
新加坡国立大学
博士研究生毕业
博士
2001.1 -- 至今
武汉大学
2000.1 -- 2001.1
新加坡材料研究与工程研究所
